A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia

A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia

Recently, the combination of VEN-HMA has been shown to achieve durable responses in patients with both newly diagnosed (ND) and R/R-AML. We retrospectively evaluated the post-allo-HCT outcomes of 50 patients who received VEN-HMA therapy. In total, 10 were ND and 40 were R/R and, at the time of HCT,...

Full description

Bibliographic Details
Main Authors: Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
acute myeloid leukemia
venetoclax
hypomethylating agents
allogeneic transplantation
Online Access:https://www.mdpi.com/2072-6694/15/6/1666

Internet

https://www.mdpi.com/2072-6694/15/6/1666

Similar Items